
Sign up to save your podcasts
Or


Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.
By allergytalk5
5151 ratings
Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.

91,297 Listeners

43,837 Listeners

87,868 Listeners

113,121 Listeners

56,944 Listeners

52 Listeners

4 Listeners

6 Listeners